Sentence examples for procedural variability from inspiring English sources

Regardless, the quality of qPCR-based CCS analysis was mildly affected by this procedural variability.

The significance of other trend-level differences, such as for the CMCT from the right hemisphere among the three groups (p = 0.068), and for the CMCT between the left and right side in controls (p = 0.075), is unclear although they may not have a significant clinical relevance, and are likely arising from procedural variability or related to the small samples size in this study.

Standardisation therefore is most important in assessing patients with more severe disease, although in the present study the procedural variables only contributed a relatively small fraction of the overall variability in H/M determinations.

By limiting the transplant setting of our study to patients with Bcr-Abl-positive CML who received T-cell-replete haploidentical transplant, we avoided procedural heterogeneities, such as variabilities in the conditioning regimens or the GVHD prophylaxis used, as well as the disease heterogeneities, as observed in many other studies.

Yet, there is uncertainty as to the risk-benefit balance of ECMO in patients with H1N1 infection, given variability in selection, procedural and logistic features involved in the implementation of such a technically demanding treatment [ 4].

Finally, the robustness of the co-incubation protocol was evaluated in terms of generalizability to other cell lines, inherent variability, and sensitivity to procedural parameters.

BACKGROUND: Postoperative bleeding remains a common, serious problem for cardiac surgery patients, with striking inter-patient variability poorly explained by clinical, procedural, and biological markers.

Along with these advantages, however, comes the possibility of inter-site variability as a result of procedural differences between the study centers, such as variations in applying the study protocol [ 1].

The inflammatory response triggered by cardiac surgery with cardiopulmonary bypass (CPB) is a primary mechanism in the pathogenesis of postoperative myocardial infarction (PMI), a multifactorial disorder with significant inter-patient variability poorly predicted by clinical and procedural factors.

The current safety paradigm is still based on ways to limit human variability in otherwise safe systems, promoting stringent procedural guidelines.

Contributing towards this are the procedural guidelines for administration of the test and low marker variability.